Use of leukocytic concentrate for preparing human interferon
Juríková, K.; Silvánová, E.; Kocisková, D.; Lackovic, V.; Borecký, L.
Bratislavske Lekarske Listy 67(6): 667-672
1977
ISSN/ISBN: 0006-9248 PMID: 884554 Document Number: 117629
Document emailed within 1 workday
Related Documents
Kvitashvili, M.A.; Kuznetsov, V.P.; Pokrovskiĭ, V.I. 1982: Treatment of severe forms of viral hepatitis with injections of human leukocytic interferon Terapevticheskii Arkhiv 54(9): 28-32Petricvić, I.; Soldo, I.; Soos, E.; Smerdel, S.; Jusić, D.; Kunsten, D. 1974: Use of human leukocytic interferon in the therapy and prevention of postvaccinal complications following mass vaccination against smallpox Lijecnicki Vjesnik 96(6): 349-354
Bostandzhian, M.G.; Dorofeeva, T.N.; Fadeeva, L.L.; Abramian, A.N.; Chmshkian, K.A. 1972: Prevention of influenza during epidemics by leukocytic interferon combined with polyvinylpyrrolidone and polyvinyl alcohol Voprosy Virusologii 17(3): 303-305
Chernushenko, E.F.; Belianovskaia, T.I.; Kuznetsova, L.V.; Shpak, O.I.; Shatrov, V.A. 1986: Effect of leukocytic interferon on the functional state of bronchoalveolar phagocytes in lung diseases Terapevticheskii Arkhiv 58(4): 83-85
Nagao, S.; Nakano, A.; Moritake, K.; Morikawa, S.; Harada, T. 1997: Synergistic antitumor effects of human interferon-beta and interferon-gamma on human gastric adenocarcinoma cells Human Cell 10(1): 95-104
Zotikov, E.A.; Tananov, A.T.; Musatova, V.S. 1976: Human leukocytic antigens (HL-A) and blood diseases Sovetskaia Meditsina 8: 25-28
Fischl, M.A.; Uttamchandani, R.B.; Resnick, L.; Agarwal, R.; Fletcher, M.A.; Patrone-Reese, J.; Dearmas, L.; Chidekel, J.; McCann, M.; Myers, M. 1991: A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(1): 1-10
Newball, H.H.; Revak, S.D.; Cochrane, C.G.; Griffin, J.H.; Lichtenstein, L.M. 1979: Activation of human Hageman factor by a leukocytic protease Advances in Experimental Medicine and Biology 120b: 139-151
Leontovich, V.A.; Abezgauz, N.N.; Troshina, V.M. 1971: Obtaining a leukocytic mass from human peripheral blood and its fractionation into granulocytes and lymphocytes Problemy Gematologii i Perelivaniia Krovi 16(1): 51-57
Chiara, M.D.; Foot, A.B.; Sobrino, F.; Jones, O.T. 1991: Differential effect of cyclosporine A on respiratory burst by several types of human leukocytic cells Biochemistry International 23(6): 1185-1193
Rubin, B.Y.; Bartal, A.H.; Anderson, S.L.; Millet, S.K.; Hirshaut, Y.; Feit, C. 1983: The anticellular and protein-inducing activities of human gamma interferon preparations are mediated by the interferon Journal of Immunology 130(3): 1019-1020
Margolick, J.B.; Ambrus, J.L.; Volkman, D.J.; Fauci, A.S. 1986: Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma Journal of Immunology 136(2): 546-554
Gustafsson, A.; Sundström, S.; Lundgren, E. 1986: The augmentation of human natural killer cell activity by interferon-gamma is not associated with the induction of the interferon-alpha-inducible proteins Journal of Immunology 137(1): 167-171
Dinarello, C.A.; Marnoy, S.O.; Rosenwasser, L.J. 1983: Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/interleukin 1 Journal of Immunology 130(2): 890-895
Simonetti, C.; Casillas, G.; Farías, C.; De los Santos, J.C. 1981: A new human factor VIIi concentrate. Preparation and clinical use Medicina 41 Suppl: 249-252
Stephan, W.; Prince, A.M.; Kotitschke, R. 1983: Factor VIIi concentrate from cold sterilized human plasma Developments in Biological Standardization 54: 491-495
Uteg, K.H.; Tausenfreund, K.; Schössler, W. 1985: In vitro characterization of human plasma fraction factor VIIi concentrate Die Pharmazie 40(4): 270
Avdeeva, Z.I.; Mazina, N.M.; Vakhromeeva, N.S.; Krylov, O.P.; Moskalenko, M.B.; Medunitsyn, N.V. 1990: The immunomodulating action of interferon preparations. 3. Changes in the phagocytic activity of human blood neutrophilic granulocytes under the influence of interferon preparations Vestnik Dermatologii i Venerologii 8: 23-28
Finbloom, D.S.; Hoover, D.L.; Wahl, L.M. 1985: The characteristics of binding of human recombinant interferon-gamma to its receptor on human monocytes and human monocyte-like cell lines Journal of Immunology 135(1): 300-305
Stancek, D.; Fuchsberger, N.; Oltman, M.; Schmeisser, H.; Kontsek, P.; Jahnová, E.; Hajnická, V. 2001: Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2 Acta Virologica 45(5-6): 287-292